Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α

The incidence and prevalence of inflammatory bowel diseases (IBDs) are rapidly increasing worldwide. IBDs are considered an emerging problem not only in Western countries but also in developing counties. The relapses and complications of active IBD mandate various medications. Nevertheless, hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jihye, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449200/
https://www.ncbi.nlm.nih.gov/pubmed/35882566
http://dx.doi.org/10.3904/kjim.2022.132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449200/
https://www.ncbi.nlm.nih.gov/pubmed/35882566
http://dx.doi.org/10.3904/kjim.2022.132

Ejemplares similares